Request Demo
Recent blog posts
Latest Hotspot
8 min read
SLC4A4 Biologics Sequence Review Report 2026: Electrogenic sodium bicarbonate cotransporter 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC4A4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC4A3 Biologics Sequence Review Report 2026: Anion exchange protein 3 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC4A3 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC4A2 Biologics Sequence Review Report 2026: Anion exchange protein 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC4A2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC4A1 Biologics Sequence Review Report 2026: Band 3 anion transport protein Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC4A1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC3A2 Biologics Sequence Review Report 2026: Amino acid transporter heavy chain SLC3A2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC3A2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC3A1 Biologics Sequence Review Report 2026: Amino acid transporter heavy chain SLC3A1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC3A1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A14 Biologics Sequence Review Report 2026: Solute carrier family 2, facilitated glucose transporter member 14 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A14 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A13 Biologics Sequence Review Report 2026: Proton myo-inositol cotransporter Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A13 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A12 Biologics Sequence Review Report 2026: Solute carrier family 2, facilitated glucose transporter member 12 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A12 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A11 Biologics Sequence Review Report 2026: Solute carrier family 2, facilitated glucose transporter member 11 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A11 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A10 Biologics Sequence Review Report 2026: Solute carrier family 2, facilitated glucose transporter member 10 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A10 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SLC2A9 Biologics Sequence Review Report 2026: Solute carrier family 2, facilitated glucose transporter member 9 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of SLC2A9 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.